The Food and Drug Administration has approved an advanced treatment for mantle cell lymphoma, a rare type of cancer that affects white blood cells. The one-time therapy, done by Gilead Sciences, is marked as Tecartus. Because it is important: This is the third federal approval for a CAR-T therapy, a …
Read More »FDA approves Gilead’s second CAR-T cancer therapy
